Steven Nissen

May Day For Dendreon (at CNBC)

Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. CNBC's Mike Huckman has the details. Cardiologist Grades Cholesterol Drug Study 16 Nov 2009 Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. Dr....

powered by

Study: New device boosts heart failure survival

N.C. Leonor developed heart failure suddenly when she had to be treated for breast cancer while pregnant with her second set of twins. The HeartMate II heart pump has kept Leonor alive for a year without the need of a heart...

powered by

Answering The Vytorin Question

Merck scores a PR win at a cardiology conference, but that doesn't mean its cholesterol drugs are effective. A trial showing that a form of niacin cleared arteries far better than Merck's Zetia cholesterol pill could have been...

powered by

Mini pump boosts heart failure survival

The Associated Press Date: Wednesday Nov. 18, 2009 8:12 AM ET ORLANDO, Fla. — For the first time, a miniature heart pump shows the potential to become a widely used, permanent treatment for many older people with severe heart...

powered by

Abbott, Arbiter & Avoidance (at CNBC)

Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. Cardiologist Grades Cholesterol Drug Study 16 Nov 2009 Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. So, I was surprised to encounter a certain...

powered by

Getting to the Heart of the Merck-Abbott Embargo Break (at CNBC)

Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. Cardiologist Grades Cholesterol Drug Study 10 hrs ago Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. Dr. Steven Nissen, chairman of the Department...

powered by

Markets News Afternoon: Car giant GM to begin repaying US government bailout; Shares up in Europe...

Markets news on stocks, currencies and oil; US car giant General Motors, which is recovering after a court bankruptcy process, announced today that it generated $3.3 billion in cash in the third quarter and plans to start...

powered by

Study questions Vytorin and Zetia in heart disease treatment

A widely prescribed and expensive cholesterol drug is not as effective as niacin, a cheap vitamin, in helping to unclog coronary arteries in people already taking statins, the standard medicines used to lower cholesterol,...

powered by

Cholesterol Study Vital for Merck

Source: New York Times | November 13, 2009 By Natasha Singer Some of Wall Street’s leading drug industry analysts are scheduled to fly to Orlando, Fla., on Sunday afternoon. For top analysts from investment banks, including...

powered by

How to Save Billions On Health Care Now

Estimated at 1.1 trillion dollars, the plan includes the so-called "public option." Video Obama: 'Fairness' In Health Care Reform Dr. Jon LaPook talks with President Obama about the cost of health care and who will pick up the...

powered by
1 2 3 4 5 next »